Associated Papers
Domain-Specific Impacts of Spike Protein Mutations on Infectivity and Antibody Escape in SARS-CoV-2 Omicron BA.1.
Kim TH et al.
Journal of Microbiology and Biotechnology, 2025
Insights into the Replication Kinetics Profiles of Malaysian SARS-CoV-2 Variant Alpha, Beta, Delta, and Omicron in Vero E6 Cell Line.
Mohd Zawawi Z et al.
International Journal of Molecular Sciences, 2024
SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease.
Ren W et al.
The Journal of Clinical Investigation, 2024
Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 Variants of Concern in Calu-3 cells.
Purwono PB et al.
Plos One, 2024
SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype.
Park SB et al.
Communications Biology, 2023
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1.
Sidarovich A et al.
Viruses, 2022
Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
Lubinski B et al.
Microbiology Spectrum, 2022
Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine.
Naaber P et al.
Cell Reports. Medicine, 2022
Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.
Lubinski B et al.
Biorxiv : the Preprint Server for Biology, 2022
Clinical Evaluation of a Fully-Automated High-Throughput Multiplex Screening-Assay to Detect and Differentiate the SARS-CoV-2 B.1.1.529 (Omicron) and B.1.617.2 (Delta) Lineage Variants.
Nörz D et al.
Viruses, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera.
Yahalom-Ronen Y et al.
Vaccines, 2022
Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike.
Lubinski B et al.
Iscience, 2022
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants.
McCallum M et al.
Science (new York, N.y.), 2021
Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization.
Zhang L et al.
Communications Biology, 2021
Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters.
Mok BW et al.
Communications Biology, 2021
The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R.
Mor O et al.
Vaccines, 2021
Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants.
McCallum M et al.
Biorxiv : the Preprint Server for Biology, 2021
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York.
West AP et al.
Nature Communications, 2021
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines.
Shen X et al.
Biorxiv : the Preprint Server for Biology, 2021